О ПЕРСПЕКТИВАХ ПРОФИЛАКТИКИ ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ У БОЛЬНЫХ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ НЕКЛАПАННОЙ ЭТИОЛОГИИ В УЗБЕКИСТАНЕ

Based on the existing scientific and statistical data in Uzbekistan, the estimated number of ischemic strokes developed due to of various clinical forms of atrial fibrillation (AF) is more than 25 thousand /year. The article provides a comparative analysis of the advantages and disadvantages of various options for pharmacological and non-pharmacological prophylaxis of ischemic strokes in accordance with the current European guidelines for the management of patients with AF (2016), taking into account the regional characteristics of the problem under study. Previously, the authors established an extremely low alertness of doctors and patient commitment to adequate anticoagulant therapy, associated in particular with a relatively high risk of bleeding, as well as other difficulties associated with controlling the effectiveness of warfarin. The experience of developed countries in solving this problem indicates the feasibility of widespread introduction into daily practice of new oral anticoagulants.